Harvard Apparatus Regenerative Technology Inc.
HRGN
$1.60
-$0.26-13.98%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -61.20% | 604.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -61.20% | 604.44% | |||
| Cost of Revenue | -62.91% | 815.15% | |||
| Gross Profit | -26.67% | 25.00% | |||
| SG&A Expenses | -6.97% | 5.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.56% | 25.36% | |||
| Operating Income | 6.49% | -9.76% | |||
| Income Before Tax | 6.75% | -9.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.75% | -9.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.75% | -9.89% | |||
| EBIT | 6.49% | -9.76% | |||
| EBITDA | 6.50% | -9.83% | |||
| EPS Basic | 12.84% | -9.88% | |||
| Normalized Basic EPS | 12.85% | -9.98% | |||
| EPS Diluted | 12.84% | -9.88% | |||
| Normalized Diluted EPS | 12.85% | -9.98% | |||
| Average Basic Shares Outstanding | 7.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 7.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||